Thymanax Европейский союз - финский - EMA (European Medicines Agency)

thymanax

servier (ireland) industries ltd - agomelatiini - masennus, masennus - psychoanaleptics, - tärkeimpien masennusoireiden hoito aikuisilla.

Valdoxan Европейский союз - финский - EMA (European Medicines Agency)

valdoxan

les laboratoires servier - agomelatiini - masennus, masennus - psychoanaleptics, - tärkeimpien masennusoireiden hoito aikuisilla.

Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Европейский союз - финский - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influenssa virus pinta-antigeenejä (haemagglutinin ja neuraminidaasin) kanta a, vietnam, 1194, 2004 (h5n1) - influenza, human; immunization; disease outbreaks - rokotteet - aktiivinen immunisaatio influenssa a -viruksen h5n1-alatyypin suhteen. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Trimbow Европейский союз - финский - EMA (European Medicines Agency)

trimbow

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoteroli fumarate dihydraatti, glykopyrroniumbromidi - keuhkosairaus, krooninen obstruktiivinen - obstruktiivisten hengitystiesairauksien lääkkeet, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.

Perlinganit 1 mg/ml infuusioneste, liuos Финляндия - финский - Fimea (Suomen lääkevirasto)

perlinganit 1 mg/ml infuusioneste, liuos

macure pharma aps - glycerol trinitrate - infuusioneste, liuos - 1 mg/ml - glyseryylitrinitraatti

Deponit Nt 5 mg / 24 tuntia depotlaastari Финляндия - финский - Fimea (Suomen lääkevirasto)

deponit nt 5 mg / 24 tuntia depotlaastari

macure pharma aps - glycerol trinitrate - depotlaastari - 5 mg / 24 tuntia - glyseryylitrinitraatti

Deponit Nt 10 mg / 24 tuntia depotlaastari Финляндия - финский - Fimea (Suomen lääkevirasto)

deponit nt 10 mg / 24 tuntia depotlaastari

macure pharma aps - glycerol trinitrate - depotlaastari - 10 mg / 24 tuntia - glyseryylitrinitraatti

CLINDAMYCIN HAMELN 150 mg/ml injektioneste, liuos Финляндия - финский - Fimea (Suomen lääkevirasto)

clindamycin hameln 150 mg/ml injektioneste, liuos

hameln pharma gmbh - clindamycini phosphas - injektioneste, liuos - 150 mg/ml - klindamysiini

AGOMELATIN SANDOZ 25 mg tabletti, kalvopäällysteinen Финляндия - финский - Fimea (Suomen lääkevirasto)

agomelatin sandoz 25 mg tabletti, kalvopäällysteinen

sandoz a/s sandoz a/s - agomelatini ureum - tabletti, kalvopäällysteinen - 25 mg - agomelatiini

Agomelatine ratiopharm 25 mg tabletti, kalvopäällysteinen Финляндия - финский - Fimea (Suomen lääkevirasto)

agomelatine ratiopharm 25 mg tabletti, kalvopäällysteinen

teva b.v. - agomelatine urea - tabletti, kalvopäällysteinen - 25 mg - agomelatiini